Works matching IS 00121622 AND DT 2025 AND VI 67 AND IP 4

Results: 33
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo‐controlled trial.

    Published in:
    Developmental Medicine & Child Neurology, 2025, v. 67, n. 4, p. 537, doi. 10.1111/dmcn.16094
    By:
    • Ottenhoff, Myrthe J.;
    • Mous, Sabine E.;
    • Castricum, Jesminne;
    • Rietman, André B.;
    • Oostenbrink, Rianne;
    • van der Vaart, Thijs;
    • Tulen, Joke H. M.;
    • Parra, Alba;
    • Ramos, Federico J.;
    • Legius, Eric;
    • Moll, Henriette A.;
    • Elgersma, Ype;
    • de Wit, Marie‐Claire Y.;
    • Taal, Walter;
    • van Dijk, Sarah;
    • de Graaff, Laura;
    • van Ierland, Yvette;
    • van Vliet, Margreethe;
    • Legerstee, Jeroen;
    • de Nijs, Pieter
    Publication type:
    Article
    32

    Table of Contents.

    Published in:
    Developmental Medicine & Child Neurology, 2025, v. 67, n. 4, p. 417, doi. 10.1111/dmcn.15968
    Publication type:
    Article
    33